A Study of CL-197 Capsules in Healthy Participants

NCT05944848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1

Interventions

DRUG: 1 mg CL-197 capsules
DRUG: 10 mg CL-197 capsules or CL-197 placebo
DRUG: 30 mg CL-197 capsules or CL-197 placebo
DRUG: 60 mg CL-197 capsules or CL-197 placebo
DRUG: 100 mg CL-197 capsules or CL-197 placebo

Sponsor

Henan Genuine Biotech Co., Ltd.